Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Selective human 5-HT1B receptor ligands in development at AstraZeneca

May 12, 1999

Cephalon initiates testing of modafinil for excessive daytime sleepiness in sleep apnea sufferers

May 12, 1999

Paxil approved in two major markets for social anxiety disorder

May 12, 1999

Anesta enters partnership with Swedish Orphan for Actiq

May 12, 1999

Safe, dose-dependent MAO-B inhibition in healthy volunteers administered SL-34.0026

May 11, 1999

Potential anxiolytics/antidepressants under development at DuPont

May 11, 1999

Substituted indan derivatives with selective affinity for 5-HT1B receptors

May 11, 1999

Single-isomer valproic acid patented in Japan

May 10, 1999

Licensing opportunity from NIH: BChE inhibitors for Alzheimer's disease Rx, Dx

May 10, 1999

Amarillo's fibromyalgia trial expanded

May 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...